GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Prostatype Genomics AB (FRA:PGO) » Definitions » Price-to-Tangible-Book

Prostatype Genomics AB (FRA:PGO) Price-to-Tangible-Book : 0.27 (As of Jun. 24, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Prostatype Genomics AB Price-to-Tangible-Book?

As of today (2024-06-24), Prostatype Genomics AB's share price is €0.0016. Prostatype Genomics AB's Tangible Book per Share of Jun. 2023 for the quarter that ended in Jun. 2023 was €0.01. Hence, Prostatype Genomics AB's Price to Tangible Book Ratio of today is 0.27.

The historical rank and industry rank for Prostatype Genomics AB's Price-to-Tangible-Book or its related term are showing as below:

During the past 5 years, Prostatype Genomics AB's highest Price to Tangible Book Ratio was 11.88. The lowest was 3.06. And the median was 7.80.

FRA:PGO's Price-to-Tangible-Book is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 2.46
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Prostatype Genomics AB's share price is €0.0016. Prostatype Genomics AB's Book Value per Sharefor the quarter that ended in Jun. 2023 was €0.01. Hence, Prostatype Genomics AB's P/B Ratio of today is 0.12.


Prostatype Genomics AB Price-to-Tangible-Book Historical Data

The historical data trend for Prostatype Genomics AB's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prostatype Genomics AB Price-to-Tangible-Book Chart

Prostatype Genomics AB Annual Data
Trend Jun18 Jun19 Dec21 Dec22 Dec23
Price-to-Tangible-Book
- - 10.79 6.65 12.80

Prostatype Genomics AB Quarterly Data
Jun18 Jun19 Mar20 Jun20 Sep20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Dec23
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.83 6.65 5.14 3.93 12.80

Competitive Comparison of Prostatype Genomics AB's Price-to-Tangible-Book

For the Diagnostics & Research subindustry, Prostatype Genomics AB's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Prostatype Genomics AB's Price-to-Tangible-Book Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Prostatype Genomics AB's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Prostatype Genomics AB's Price-to-Tangible-Book falls into.



Prostatype Genomics AB Price-to-Tangible-Book Calculation

Prostatype Genomics AB's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Jun. 2023 )
=0.0016/0.006
=0.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Prostatype Genomics AB Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Prostatype Genomics AB's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Prostatype Genomics AB (FRA:PGO) Business Description

Traded in Other Exchanges
Address
Gustaf III:s Boulevard 34, Solna, SWE, 169 73
Prostatype Genomics AB manufactures, markets and sells the prognostic gene test Prostatype. By assessing the aggressiveness of prostate cancer, Prostatype helps clinicians and patients to make correct treatment decisions. Over and under treatment of prostate cancer can be minimized, the quality of life for the patient improved and money can be saved for the health care sector.

Prostatype Genomics AB (FRA:PGO) Headlines

No Headlines